Discontinued drugs in 2011: cardiovascular drugs

被引：5
|
作者：
Zhao, Hong-Ping [1 ]
Jiang, Hong-Min [1 ]
Xiang, Bing-Ren [1 ]
机构：
[1] China Pharmaceut Univ, Ctr Instrumental Anal, Key Lab Drug Qual Control & Pharmacovigilance, Minist Educ, Nanjing 210009, Jiangsu, Peoples R China
来源：
EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2012年 / 21卷 / 10期
关键词：
ADX-415; alipogene tiparvovec; antihypertensives-NicOx-1; antihypertensives-NicOx-2; avotermin; BMS-844421; budiodarone; celivarone; cinaciguat; darexaban maleate; flovagatran; GRNCM1; GS-9667; letaxaban; OBE-101; PPD-10558; SB-509; sirolimus stent-J&J; tecarfarin;
D O I：
10.1517/13543784.2012.710198
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
This perspective is part of an annual series of papers discussing drugs dropped from development in the previous year. Specifically, this paper focuses on the 19 cardiovascular drugs discontinued in 2011 after reaching preclinical or Phase I - III clinical trials. Information for this perspective is mainly derived from a search of Pharmaprojects.
引用
收藏
页码：1449 / 1462
页数：14
相关论文
共 50 条
  • [1] Discontinued drugs in 2011: oncology drugs
    Williams, Robert
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (01) : 9 - 34
  • [2] Discontinued drugs in 2008: cardiovascular drugs
    Zhang, Xu-song
    Xiang, Bing-ren
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (07) : 875 - 885
  • [3] Discontinued drugs in 2012: cardiovascular drugs
    Zhao, Hong-Ping
    Jiang, Hong-Min
    Xiang, Bing-Ren
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (11) : 1437 - 1451
  • [4] Discontinued drugs in 2010: cardiovascular drugs
    Zhao, Hong-ping
    Zhang, Xu-song
    Xiang, Bing-ren
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (10) : 1311 - 1325
  • [5] Discontinued drugs in 2007: cardiovascular drugs
    Zhang Xu-song
    Xiang Bing-ren
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (12) : 1817 - 1828
  • [6] Discontinued drugs in 2005: cardiovascular drugs
    Suckling, Keith
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (11) : 1299 - 1308
  • [7] Discontinued cardiovascular drugs in 2015
    Zhao, Hong-ping
    Dai, Yan
    Xiang, Bing-ren
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (09) : 1093 - 1101
  • [8] Discontinued drugs 2011: endocrine and metabolic
    Colca, Jerry R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (11) : 1619 - 1624
  • [9] Discontinued cardiovascular drugs in 2013 and 2014
    Zhao, Hong-ping
    Xiang, Bing-ren
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (08) : 1083 - 1092
  • [10] Discontinued drugs in 2006: Cardiovascular drugs translational medicine perspective
    Feuerstein, Giora Z.
    Ruffolo, Robert R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (09) : 1315 - 1326
12345